Categories: News

Prismforce Launches AIQ to Close the Gap Between AI Investment and Workforce Readiness

Strategic platform that defines future roles, baselines workforce AI readiness, and drives targeted upskilling and talent transformation

- Advertisement -

MUMBAI, India, April 27, 2026 /PRNewswire/ — Prismforce, a global leader in AI-powered workforce transformation, today announced the launch of AIQ (AI Quotient). This platform benchmarks AI expectations by role, measures workforce capability across six dimensions, and prescribes actions to close gaps—aligning talent strategies with AI-driven business priorities.

- Advertisement -

The launch comes amid surging AI investment, yet a growing disconnect between AI investment and workforce readiness. While 92% of organizations are increasing AI spending, only 1% consider themselves AI-mature, and nearly half of core skills are expected to evolve by 2027. This underscores the urgency for leaders to realign workforce capabilities with the demands of an AI-driven enterprise.

- Advertisement -

Built on Prismforce’s proprietary role-skill-task intelligence, AIQ transforms workforce AI readiness from an abstract concept into a measurable, actionable framework—replacing guesswork with clarity. The platform models how AI is reshaping roles, identifies emerging and evolving roles, and establishes a clear baseline of workforce capability. It measures workforce capability using skill profiles, AI-driven inference, usage data, and assessments across six dimensions, giving business leaders a structured view of workforce AI readiness.

- Advertisement -

“AI is not simply changing how work gets done; it is redefining the workforce model itself,” said Somnath Chatterjee, Founder & CEO, Prismforce. “AIQ reflects our broader strategy to advance AI readiness as part of talent transformation. As enterprises rethink work structures, leaders need to understand which roles are evolving, which capabilities will define future success, and where critical gaps exist. AIQ helps enterprises anticipate these shifts early and translate them into targeted talent transformation strategies.”

- Advertisement -

AIQ is available immediately through the Prismforce platform, enabling a more structured approach to AI-driven workforce planning.

- Advertisement -

About Prismforce

- Advertisement -

Prismforce is an AI-powered platform that helps enterprises build future-ready workforces through skills intelligence and agentic AI. Its cloud-native suite unifies skill intelligence, talent marketplace, staffing, skilling, demand forecasting, and hiring. This enables enterprises to plan, staff, and deliver projects faster while unlocking richer career paths for their people. The platform drives both business performance and employee engagement by making talent operations smarter and more efficient.

- Advertisement -

Backed by Sequoia Capital, Prismforce has a global presence with a team of 200+ experts. It currently serves over 700,000 users across 30+ leading IT services and technology companies worldwide. The company is expanding its capabilities into adjacent sectors as enterprise needs evolve in an AI-first era.

- Advertisement -

‍Visit www.prismforce.com

- Advertisement -

Photo: https://mma.prnewswire.com/media/2966310/Prismforce_Founder_CEO.jpg
Logo: https://mma.prnewswire.com/media/2839425/Prismforce_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/prismforce-launches-aiq-to-close-the-gap-between-ai-investment-and-workforce-readiness-302754100.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

4 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

8 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

8 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

8 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

8 hours ago